Dr Poonam Suryawanshi
Also known as: Poonam Kadam, Dr Poonam Suryawanshi
Dr. D.Y. Patil Vidyapeeth, Pune
About
Experienced immunologist with over ten years of research expertise in viral immunology, immunopathogenesis, innate immune responses, and mucosal immunology, with a focus on HIV and COVID-19. Proficient in a broad spectrum of immunological assays, including ELISpot, bead-based multiplex immunoassays (Luminex), antibody-dependent cellular cytotoxicity (ADCC) assays, intracellular cytokine staining, cytotoxicity, apoptosis, and cell cycle detection. Extensive experience with flow cytometry and immune cell isolation techniques, including immunophenotyping and cell sorting on platforms such as BD FACS Lyric and BD FACS Fusion. Skilled in molecular methods like DNA/RNA extraction, cDNA synthesis, and multiplex quantitative real-time PCR for gene detection. Demonstrated ability to design, conduct, and analyze complex experiments, with a strong publication history and a wealth of experience in scientific writing and data analysis.
Employment
-
Dr. D.Y. Patil Vidyapeeth, Pune Research Scientist2023 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- The emerging role of unconventional T cells in active pulmonary tuberculosis: Current insights and future perspectives Save
- Unveiling the Pros and Cons of Liquid-Based Cytology for Cervical Cancer Screening Save
- Antimicrobial resistance patterns and methicillin resistant Staphylococcus aureus among clinical isolates in a tertiary care hospital of Western Maharashtra Save
- Daily intranasal sesame oil instillation to improve nasal barrier function and mucosal immunity for respiratory health: A pilot randomized trial in healthy adults Save
- Exploring the Differentiation Abilities of Hair Follicle and Dental Pulp Stem Cells Into Islet Like Cells Save
- Scrub Typhus taking Center Stage again! Save
- Undiagnosed Sleep Apnea: Exacerbating the Postcoronavirus Disease Symptoms? Save
- T‐cell responses in COVID‐19 survivors 6−8 months after infection: A longitudinal cohort study in Pune Save
- Neutralizing Antibodies against SARS-CoV2 Save
- T-cell responses in COVID-19 survivors six to eight months after infection: a longitudinal cohort study in Pune Save